| scholarly article | Q13442814 |
| P2093 | author name string | Robert M Strieter | |
| P2860 | cites work | Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes | Q29547633 |
| Obesity induces a phenotypic switch in adipose tissue macrophage polarization | Q29547686 | ||
| Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease | Q30442380 | ||
| The role of CXC chemokines in pulmonary fibrosis | Q30443091 | ||
| Structure, strength, failure, and remodeling of the pulmonary blood-gas barrier | Q33547255 | ||
| Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans | Q34028910 | ||
| Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion | Q34558931 | ||
| Bone marrow-derived progenitor cells in pulmonary fibrosis | Q35022598 | ||
| Inducible expression of keratinocyte growth factor (KGF) in mice inhibits lung epithelial cell death induced by hyperoxia | Q35022890 | ||
| Infectious disease, the innate immune response, and fibrosis | Q35649461 | ||
| Intraluminal fibrosis in interstitial lung disorders | Q35835974 | ||
| TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing | Q35841836 | ||
| Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis | Q36028616 | ||
| Basement membrane peptides: functional considerations and biomedical applications in autoimmunity. | Q36172906 | ||
| Macrophage polarization comes of age. | Q36287066 | ||
| Pathogenesis and natural history of usual interstitial pneumonia: the whole story or the last chapter of a long novel | Q36320206 | ||
| Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis | Q36399732 | ||
| Regulation of fibrosis by the immune system | Q36472048 | ||
| Inflammation-associated remodelling and fibrosis in the lung - a process and an end point | Q36780178 | ||
| Fibrocytes in lung disease | Q36841197 | ||
| Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis | Q36849123 | ||
| Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum | Q37110217 | ||
| Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung | Q37370914 | ||
| Macrophages and polymorphonuclear neutrophils in lung defense and injury | Q38140729 | ||
| Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis | Q40339595 | ||
| Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. | Q40474320 | ||
| Infection-induced modulation of m1 and m2 phenotypes in circulating monocytes: role in immune monitoring and early prognosis of sepsis | Q40503204 | ||
| Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis | Q40662352 | ||
| Basics of cutaneous wound repair | Q40834153 | ||
| The role of the CC chemokine, RANTES, in acute lung allograft rejection | Q41742536 | ||
| Elastic tissue of normal and emphysematous lungs. A tridimensional histologic study. | Q42042157 | ||
| An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis | Q42496001 | ||
| Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma | Q46224631 | ||
| Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia | Q47446738 | ||
| Fine structural changes in cryptogenic fibrosing alveolitis and asbestosis | Q47601459 | ||
| Thoracic lymph node enlargement in usual interstitial pneumonitis and nonspecific-interstitial pneumonitis: prevalence, correlation with disease activity and temporal evolution. | Q53512065 | ||
| Idiopathic pulmonary fibrosis. A paradigm for lung injury and repair | Q68201994 | ||
| Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis | Q83276267 | ||
| P433 | issue | 3 | |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 305-310 | |
| P577 | publication date | 2008-04-01 | |
| P1433 | published in | Proceedings of the American Thoracic Society | Q7247176 |
| P1476 | title | What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis | |
| P478 | volume | 5 |
| Q89566450 | A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis |
| Q42702771 | A translational preclinical model of interstitial pulmonary fibrosis and pulmonary hypertension: mechanistic pathways driving disease pathophysiology |
| Q38008342 | Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair |
| Q38103933 | Adenosine signaling pathways as potential therapeutic targets in respiratory disease |
| Q28748902 | Alterations in adenosine metabolism and signaling in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis |
| Q46593881 | Analysis of gene expression in canine idiopathic pulmonary fibrosis |
| Q33830299 | Angiotensin-II-induced apoptosis requires regulation of nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells |
| Q37133696 | Bleomycin (BLM) Induces Epithelial-to-Mesenchymal Transition in Cultured A549 Cells via the TGF-β/Smad Signaling Pathway |
| Q26777474 | Breakdown of Epithelial Barrier Integrity and Overdrive Activation of Alveolar Epithelial Cells in the Pathogenesis of Acute Respiratory Distress Syndrome and Lung Fibrosis |
| Q37030035 | Computational Modeling Predicts Simultaneous Targeting of Fibroblasts and Epithelial Cells Is Necessary for Treatment of Pulmonary Fibrosis. |
| Q93216677 | Conditional deletion of Nedd4-2 in lung epithelial cells causes progressive pulmonary fibrosis in adult mice |
| Q50052813 | Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment |
| Q28392980 | Differential susceptibility of inbred mouse strains to chlorine-induced airway fibrosis |
| Q35406879 | Dihydroartemisinin supresses inflammation and fibrosis in bleomycine-induced pulmonary fibrosis in rats |
| Q37707609 | Diverse macrophage populations mediate acute lung inflammation and resolution |
| Q36301478 | EBM regeneration and changes in EBM component mRNA expression in stromal cells after corneal injury |
| Q36907395 | Effects of CpG Oligodeoxynucleotide 1826 on transforming growth factor-beta 1 and radiation-induced pulmonary fibrosis in mice |
| Q47952164 | Effects of nintedanib on the microvascular architecture in a lung fibrosis model |
| Q37744240 | Endothelin in pulmonary fibrosis |
| Q33916933 | Epithelial repair mechanisms in the lung |
| Q42874222 | Evidence for a functional thymic stromal lymphopoietin signaling axis in fibrotic lung disease |
| Q36778823 | Fibroblast Activation Protein (FAP) Accelerates Collagen Degradation and Clearance from Lungs in Mice |
| Q37404782 | Global gene expression patterns in the post-pneumonectomy lung of adult mice |
| Q55045366 | Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence. |
| Q41949357 | Identifying Mechanisms of Homeostatic Signaling in Fibroblast Differentiation |
| Q38713268 | Identifying mechanisms driving formation of granuloma-associated fibrosis during Mycobacterium tuberculosis infection |
| Q47901631 | Idiopathic Pulmonary Fibrosis: Molecular Endotypes of Fibrosis Stratifying Existing and Emerging Therapies |
| Q92702927 | Idiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs |
| Q41439207 | Increased circulating fibrocytes are associated with higher reticulocyte percent in children with sickle cell anemia |
| Q36222986 | Increased fibroblast telomerase expression precedes myofibroblast α-smooth muscle actin expression in idiopathic pulmonary fibrosis |
| Q38057707 | Influence of age on wound healing and fibrosis |
| Q39381291 | Injury and defective regeneration of the epithelial basement membrane in corneal fibrosis: A paradigm for fibrosis in other organs? |
| Q37598532 | Innate Immune Pathways Associated with Lung Radioprotection by Soy Isoflavones |
| Q35550738 | Is there a regulatory role of immunoglobulins on tissue forming cells relevant in chronic inflammatory lung diseases? |
| Q39673639 | Macrophage bone morphogenic protein receptor 2 depletion in idiopathic pulmonary fibrosis and Group III pulmonary hypertension |
| Q97546967 | Macrophage polarization and its role in the pathogenesis of acute lung injury/acute respiratory distress syndrome |
| Q92703110 | Matrisome Properties of Scaffolds Direct Fibroblasts in Idiopathic Pulmonary Fibrosis |
| Q47221688 | Matrix biomechanics and dynamics in pulmonary fibrosis |
| Q35235706 | Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis |
| Q23910481 | Multi-walled carbon nanotubes induce human microvascular endothelial cellular effects in an alveolar-capillary co-culture with small airway epithelial cells |
| Q37709579 | New developments in the therapy of pulmonary fibrosis |
| Q58738623 | Phosphatidylethanolamine Induces an Antifibrotic Phenotype in Normal Human Lung Fibroblasts and Ameliorates Bleomycin-Induced Lung Fibrosis in Mice |
| Q39071297 | Plasma membrane wounding and repair in pulmonary diseases |
| Q42220886 | Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A(4) synthetic analog |
| Q37349730 | Relevance of granulocyte apoptosis to resolution of inflammation at the respiratory mucosa. |
| Q33719352 | Resistance to bleomycin-induced lung fibrosis in MMP-8 deficient mice is mediated by interleukin-10 |
| Q37789644 | Respiratory epithelial cells in innate immunity to influenza virus infection |
| Q50957855 | Role of insulin like growth factor axis in the bleomycin induced lung injury in rats. |
| Q50795417 | Stem cells and pulmonary fibrosis: cause or cure? |
| Q23910477 | System-based identification of toxicity pathways associated with multi-walled carbon nanotube-induced pathological responses |
| Q23910480 | Systematic analysis of multi-walled carbon nanotube-induced cellular signaling and gene expression in human small airway epithelial cells |
| Q37972797 | Targeting stroma to treat cancers |
| Q28076264 | The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease |
| Q27301282 | The LIM-only protein FHL2 attenuates lung inflammation during bleomycin-induced fibrosis |
| Q41900872 | The NF-kappaB p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes |
| Q33590992 | The TGF-beta-pseudoreceptor BAMBI is strongly expressed in COPD lungs and regulated by nontypeable Haemophilus influenzae. |
| Q37852901 | The lens as a model for fibrotic disease |
| Q30427773 | The role of fibrocytes in sickle cell lung disease |
| Q38024820 | The role of macrophages in healing the wounded lung |
| Q23915560 | mRNA and miRNA regulatory networks reflective of multi-walled carbon nanotube-induced lung inflammatory and fibrotic pathologies in mice |
| Q23910476 | mRNAs and miRNAs in whole blood associated with lung hyperplasia, fibrosis, and bronchiolo-alveolar adenoma and adenocarcinoma after multi-walled carbon nanotube inhalation exposure in mice |
Search more.